Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study.
Pinato DJ, Mauri FA, Spina P, Cain O, Siddique A, Goldin R, Victor S, Pizio C, Akarca AU, Boldorini RL, Mazzucchelli L, Black JRM, Shetty S, Marafioti T, Sharma R.
Pinato DJ, et al.
Br J Cancer. 2019 May;120(11):1033-1036. doi: 10.1038/s41416-019-0466-x. Epub 2019 May 7.
Br J Cancer. 2019.
PMID: 31061454
Free PMC article.